|
|
|||||||||||||||||||||||
|
>> Home > Smoking & Tobacco > Health Professionals | ||||||||||||||||||||||
Smoking and Pregnancy
There are many reasons why women have such a hard time quitting during pregnancy. The foremost reason being that smoking is an addiction which usually requires behavioural therapy and pharmacotherapy. On their own, only 20% of smokers quit sometime during their pregnancy. Evidence demonstrates the minimal interventions provided by health professionals, coupled with self-help material tailored for pregnant women, are effective in increasing quit rates. Clinicians’ interventions have the potential to generate rates that are a 30% to 70% increase above the regular quit rates.
"The 5 A’s", is the minimal intervention approach used in the 2000 Clinical Practice Guidelines for Physicians in the United States. Outlined below are the steps in The 5 A’s for pregnant women (Melvin, 2004); Ask the women about any smoking habits using a multiple-choice question to increase response reliability. For example:
A A A Minimal Intervention – print-out reference sheet (note: this reference sheet uses the Registered Nurses Association of Ontario’s 4 A’s instead of the 5 A’s. The ‘Assess’ step is incorporated into the ‘Arrange’ step.) For addicted smokers, behavioural therapy is not normally enough to achieve smoking cessation; pharmacological therapy is often necessary. This is just as true for pregnant women as well. Some highly addicted heavy smokers are just not able to quit when they become pregnant. Nicotine replacement therapies (NRTs) for pregnant women are not without risk. However this risk may be far less than the risk of continued smoking (Benowitz, 2004). Uteroplacental insufficiency has been the accepted key mechanism by which nicotine causes adverse outcomes. Previously it had been thought that the cardiovascular effect of nicotine reduces blood flow through the placenta causing the negative effects of smoking during pregnancy. However, researchers are now proposing that "cellular and molecular abnormalities produced by tobacco smoke toxins, acting alone or in concert, produce a wide range of adverse pregnancy outcomes" (Dempsey, 2001). In animal trials, nicotine is thought to be toxic to the development of the CNS, and it may be involved in occurrence of SIDS, nevertheless, the risks associated with nicotine must be compared to the risks associated with continued smoking (Dempsey, 2001). Continuing to smoke exposes the fetus to toxic substances including carbon monoxide, formaldehyde, arsenic, and benzoapyrene all which have negative effects in humans. The choice to use a NRT should be made on a client-to-client basis keeping these guidelines/suggestions in mind (Benowtiz, 2004)
Smoking Cessation for Pregnant and Post-partum Women: A Toolkit for Health Professionals Available at www.pregnets.org
For more information on NRT in pregnancy see: Benowtiz NL, Dempsey, DA., Pharmacotherapy for smoking cessation during pregnancy. Nicotine & Tobacco Research. Volume 6, Supplement 2. April 2004. S189-S202. |
|||||||||||||||||||||||
We work with the Grey Bruce community to protect and promote health |
|||||||||||||||||||||||